"Concerns that females with an autoimmune disease might be predisposed to develop a second autoimmune disorder if exposed to the human papilloma virus (HPV) vaccine are unfounded, because girls and women who receive the vaccine are slightly less l"...
Ilaris Patient Information including If I Miss a Dose
In this Article
- What is canakinumab (Ilaris)?
- What are the possible side effects of canakinumab (Ilaris)?
- What is the most important information I should know about canakinumab (Ilaris)?
- What should I discuss with my health care provider before using canakinumab (Ilaris)?
- How should I use canakinumab (Ilaris)?
- What happens if I miss a dose (Ilaris)?
- What happens if I overdose (Ilaris)?
- What should I avoid while using canakinumab (Ilaris)?
- What other drugs will affect canakinumab (Ilaris)?
- Where can I get more information?
What happens if I miss a dose (Ilaris)?
Call your doctor for instructions if you miss a dose of this medicine.
What happens if I overdose (Ilaris)?
Seek emergency medical attention if you think you have used too much of this medicine.
Symptoms of a canakinumab overdose are not known.
What should I avoid while using canakinumab (Ilaris)?
Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.
Do not receive a "live" vaccine while you are being treated with canakinumab. The live vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), oral polio, chickenpox (varicella), BCG (Bacillus Calmette and Guérin), and nasal flu vaccine.
Make sure you are current on all vaccines before you begin treatment with canakinumab.
What other drugs will affect canakinumab (Ilaris)?
Tell your doctor about all other medications you use, especially:
- adalimumab (Humira);
- certolizumab (Cimzia);
- cyclosporine (Gengraf, Neoral, Sandimmune);
- digoxin (digitalis, Lanoxin, Lanoxicaps);
- etanercept (Enbrel);
- golimumab (Simponi);
- infliximab (Remicade);
- a blood thinner such as warfarin (Coumadin);
- sirolimus (Rapamune) or tacrolimus (Prograf);
- theophylline (Elixophyllin, Theo-24, Uniphyl);
- seizure medication such as carbamazepine (Carbatrol, Tegretol), divalproex (Depakote), phenytoin (Dilantin), or valproic acid (Depakene); or
- a heart rhythm medication such as disopyramide (Norpace), procainamide (Procan, Pronestyl), or quinidine (Quinidex, Quin-Release Quin-G).
This list is not complete and there may be other drugs that can interact with canakinumab. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about canakinumab.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 1.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Ilaris Information
- Ilaris Drug Interactions Center: canakinumab (pf) subq
- Ilaris Side Effects Center
- Ilaris Overview including Precautions
- Ilaris FDA Approved Prescribing Information including Dosage
Ilaris - User Reviews
Ilaris User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.